Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 9, 2017 - Issue
Submit an article Journal homepage
72
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain

Santiago Grau1 Pharmacy Department, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona
,
Jose Ramon Azanza2 Clinical Pharmacology Department, Clínica Universidad de Navarra, Pamplona
,
Isabel Ruiz3 Infectious Diseases Department, Hospital Universitari Vall d’Hebron, Barcelona
,
Carlos Vallejo4 Hematology Department, Hospital Universitario Donostia, San Sebastián
,
Josep Mensa5 Infectious Diseases Department, Hospital Clínic de Barcelona, Barcelona, Spain
,
Johan Maertens6 Hematology Department, University Hospital Gasthuisberg, Leuven, Belgium
,
Werner J Heinz7 Hematology/Oncology Department, Medizinische Klinik und Poliklinik II, Universitätsklinikum, Würzburg, Germany
,
Jon Andoni Barrueta8 Medical Department
,
Carmen Peral9 Economics and Outcomes Research Department, Pfizer S.L.U, Alcobendas
,
Francisco Jesús Mesa8 Medical Department
,
Miguel Barrado10 Clinical Trials Department, Trial Form Support, Madrid, Spain
,
Claudie Charbonneau11 Pharmacoeconomics Department, Pfizer International Operations, Paris, France
,
Darío Rubio-Rodríguez12 Pharmacoeconomics Department, Health Value, Madrid, SpainCorrespondence[email protected]
&
Carlos Rubio-Terrés12 Pharmacoeconomics Department, Health Value, Madrid, Spain
 show all
Pages 39-47 | Published online: 30 Dec 2016

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mateusz Szymański, Sandra Chmielewska, Urszula Czyżewska, Marta Malinowska & Adam Tylicki. (2022) Echinocandins – structure, mechanism of action and use in antifungal therapy. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 876-894.
Read now

Articles from other publishers (2)

José Ramón Azanza, Santiago Grau, Lourdes Vázquez, Pablo Rebollo, Carmen Peral, Alejandra López‐Ibáñez de Aldecoa & Vanessa López‐Gómez. (2020) The cost‐effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain. Mycoses 64:1, pages 66-77.
Crossref
. (2017) Anidulafungin + voriconazole cost effective for IA in Spain. PharmacoEconomics & Outcomes News 770:1, pages 4-4.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.